|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:alsoKnownAs
|
gptkb:MSD_outside_United_States_and_Canada
|
|
gptkbp:awards
|
gptkb:Fortune_World's_Most_Admired_Companies
gptkb:Dow_Jones_Sustainability_Index
|
|
gptkbp:CEO
|
gptkb:Robert_M._Davis
|
|
gptkbp:Fortune500Rank
|
71 (2023)
|
|
gptkbp:founded
|
1891
|
|
gptkbp:founder
|
gptkb:George_Merck
|
|
gptkbp:headquartersLocation
|
gptkb:Kenilworth,_New_Jersey,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Merck & Co., Inc.
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:memberOf
|
gptkb:Pharmaceutical_Research_and_Manufacturers_of_America_(PhRMA)
gptkb:International_Federation_of_Pharmaceutical_Manufacturers_&_Associations_(IFPMA)
|
|
gptkbp:notableAcquisition
|
gptkb:Cubist_Pharmaceuticals_(2015)
gptkb:Pandion_Therapeutics_(2021)
gptkb:Schering-Plough_(2009)
Acceleron Pharma (2021)
Afferent Pharmaceuticals (2016)
Antelliq (2019)
Prometheus Biosciences (2023)
|
|
gptkbp:notableCase
|
Gardasil lawsuits
Vioxx lawsuits
|
|
gptkbp:notableProduct
|
gptkb:Gardasil
gptkb:Isentress
gptkb:Januvia
gptkb:Keytruda
gptkb:Propecia
gptkb:Singulair
gptkb:Zetia
gptkb:Vioxx
|
|
gptkbp:nowPartOf
|
gptkb:Merck_Group_(Germany)
|
|
gptkbp:numberOfEmployees
|
~69,000 (2023)
|
|
gptkbp:parentCompany
|
independent
|
|
gptkbp:revenue
|
$59.3 billion (2023)
|
|
gptkbp:S&P500Component
|
yes
|
|
gptkbp:separates
|
gptkb:Merck_KGaA_(after_World_War_I)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:MRK
|
|
gptkbp:subsidiary
|
gptkb:Merck_Research_Laboratories
gptkb:MSD_Animal_Health
|
|
gptkbp:therapeuticArea
|
gptkb:diabetes
animal health
infectious diseases
oncology
vaccines
cardiovascular
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.merck.com/
|
|
gptkbp:bfsParent
|
gptkb:默沙东
gptkb:MRK
|
|
gptkbp:bfsLayer
|
5
|